Amyris To Acquire Menolabs For Menopause Wellness Accelerating Growth Of Consumer Business
Acquiring Company
Amyris
Acquired Company
MenoLabs
EmeryvilleManufacturingBiotechnologyHealth CareDescription
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-MarketTM operating platform announces that it has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a women-founded company to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.
Who to call at Amyris, and when
When Amyris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Amyris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amyris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amyris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amyris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired MenoLabs?
MenoLabs was acquired by Amyris, based in Emeryville. The deal was reported on January 24, 2022. Amyris is a global leader in renewable biological chemistry, powered by decades of experience and a world-class technology and manufacturing platform. Amyris is privately held and operates in Manufacturing.
When did Amyris acquire MenoLabs?
Amyris's acquisition of MenoLabs was reported on January 24, 2022. Amyris, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MenoLabs do?
MenoLabs was founded to fundamentally change how menopause is addressed. It is privately held, operating in Health Care.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.